According to our new market research study on “South and Central America Organoids Market to 2027 - Regional Analysis and Forecast - by Type, Application, and Source” the market is expected to US$ 98.85 million by 2027 from US$ 27.12 million in 2019 and the market is expected to grow at a CAGR of 20.3% from 2020 to 2027. The report provides trends prevailing in the South and Central America organoids market and the factors driving the market growth along with those hindering it.
By application, however drug discovery and personalized medicine is expected to register CAGR of 21.8% in the market during the period 2020-2027. The development of new drugs is currently a long and costly process In large part due to the failure of promising drug candidates identified in initial in vitro screens to perform as intended in vivo. New approaches to drug screening are being developed which focus on providing more biomimetic platforms. Pharmaceutical companies are looking for ways to save time and money in the drug discovery process. If there was a way to determine a therapys impact in the pre-clinical process, researchers would have a better understanding of where to focus their efforts. This is where organoids come in.
The growth of the South and Central America organoids market is mainly attributed to the increasing adoption of personalized drugs and drug discovery, growing focus on reducing animal use in research. However, issues related to the lack of skilled professionals are the major factor hindering the market growth.
STEMCELL Technologies, Inc, Thermo Fisher Scientific, Corning Incorporated (Life Sciences), Merck KGgA are among the leading companies operating in the South and Central America organoids market.
The report segments South and Central America Organoids Market as follows:
By Type
By Application
By Source
By Country
Reasons to Buy
It provides understanding of the South and Central America organoids market landscape and identifies organoids market segments that are most likely to guarantee a strong return.It guides
Stay ahead of the race by comprehending the ever-changing competitive landscape for the South and Central America organoids market.It helps
Efficiently plan merger and acquisition, and partnership deals in the organoids market by identifying market segments with the most promising probable sales
It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of organoids market performance of various segments pertaining to the South and Central America organoids market.
It provides organoids market revenue forecast of the market based on various segments for the period from 2019 to 2027.
By application, however drug discovery and personalized medicine is expected to register CAGR of 21.8% in the market during the period 2020-2027. The development of new drugs is currently a long and costly process In large part due to the failure of promising drug candidates identified in initial in vitro screens to perform as intended in vivo. New approaches to drug screening are being developed which focus on providing more biomimetic platforms. Pharmaceutical companies are looking for ways to save time and money in the drug discovery process. If there was a way to determine a therapys impact in the pre-clinical process, researchers would have a better understanding of where to focus their efforts. This is where organoids come in.
The growth of the South and Central America organoids market is mainly attributed to the increasing adoption of personalized drugs and drug discovery, growing focus on reducing animal use in research. However, issues related to the lack of skilled professionals are the major factor hindering the market growth.
STEMCELL Technologies, Inc, Thermo Fisher Scientific, Corning Incorporated (Life Sciences), Merck KGgA are among the leading companies operating in the South and Central America organoids market.
The report segments South and Central America Organoids Market as follows:
By Type
- Stomach
- Intestine
- Liver
- Pancreas
- Lung
- Brain
- Kidney
- Others
By Application
- Developmental Biology
- Disease Pathology of Infectious Disease
- Regenerative Medicine
- Drug Toxicity and Efficacy Testing
- Drug Discovery and Personalized Medicine
- Others
By Source
- Pluripotent Stem Cells
- Organ-specific Adult Stem Cells
By Country
- Brazil
- Argentina
- Rest of South and Central America
Reasons to Buy
It provides understanding of the South and Central America organoids market landscape and identifies organoids market segments that are most likely to guarantee a strong return.It guides
Stay ahead of the race by comprehending the ever-changing competitive landscape for the South and Central America organoids market.It helps
Efficiently plan merger and acquisition, and partnership deals in the organoids market by identifying market segments with the most promising probable sales
It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of organoids market performance of various segments pertaining to the South and Central America organoids market.
It provides organoids market revenue forecast of the market based on various segments for the period from 2019 to 2027.
Table of Contents
1. Introduction
3. Research Methodology
4. Organoids - Market Landscape
5. Organoids Market - Key Market Dynamics
6. Organoids Market - South and Central America Analysis
7. Organoids Market Analysis - By Type
8. Organoids Market Analysis - By Application
9. Organoids Market Analysis - By Source
10. Organoids Market - Geographic Analysis
11. Impact of COVID-19 Pandemic on South and Central America Organoids Market
12. Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- STEMCELL Technologies, Inc
- Thermo Fisher Scientific
- Corning Incorporated (Life Sciences)
- Merck KGgA
